Jenburkt Pharmaceuticals Ltd Share Price History
Jenburkt Pharmaceuticals Ltd
NSE : 09 Nov, 2026
953.75-20.3 (-2.1%)
Prev Close
974.0
Open Price
980.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
308
Today's High / Low
980.0 / 951.2
52 WK High / Low
1073.9 / 845.0
Market Price of Jenburkt Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Jenburkt Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 105 |
| Sales YoY Gr. | - |
| Adj EPS | 29.05 |
| YoY Gr. | - |
| Net Profit (Cr.) | 14 |
| BVPS | 117.09 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 37.23 |
| Op. Profit Mgn % | 21.62 |
| Net Profit Mgn % | 12.88 |
| Debt to Equity % | 0.12 |
Latest Shareholding
Promoters Holdings Over Time
About Jenburkt Pharmaceuticals Ltd
- Jenburkt Pharmaceuticals Limited was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family during the period 1986.
- The Company engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.
- It works more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe.
- The organisation serve to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all.
- Way back in the 20th century, a visionary in the field of healthcare and philanthropic work - Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies.
Popular Search
FAQs for Jenburkt Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Jenburkt Pharmaceuticals Ltd's share price history?
Key events that impact Jenburkt Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Jenburkt Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Jenburkt Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Jenburkt Pharmaceuticals Ltd?
Dividends can influence Jenburkt Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Jenburkt Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Jenburkt Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Jenburkt Pharmaceuticals Ltd’s share price history?
To understand Jenburkt Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
